FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (IIB) or a pharmaceutically acceptable salt thereof. In formula (IIB), E is -CH2-; Q represents -CH2-; Z is hydrogen or methyl; V is N; R12 is hydrogen; R15 represents a difluoromethoxy group; R16 is hydrogen; R21 represents hydroxy (C1-C6)alkyl and R23 is hydrogen. Also the invention relates to a pharmaceutical composition, to the use of a compound, to a method for treating and/or preventing rheumatoid arthritis or Crohn's disease.
.
EFFECT: obtained is a new compound of formula (IIB), which has the properties of a modulator of TNFα activity.
6 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2683318C1 |
PURINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684644C1 |
IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2695664C1 |
CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2687093C1 |
PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
BENZOTRIAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677696C1 |
IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
Authors
Dates
2019-01-21—Published
2014-12-08—Filed